Back to Treatments

Treatment

Sunitinib

1
Conditions
241
Trials
1,500
Participants
30%
Average Safety

Condition Evidence

Kidney cancer

241 trials · 1,500 participants

65% effectiveness · 30% safety
Sunitinib | DFDA